Abstract
Recently, interest in specific pharmacological antagonists to angiotensin has grown (Godfraind, 1968). Since angiotensin has a wide spectrum of actions and stimulates smooth muscle both directly and indirectly it is convenient to describe the antagonists in two categories:
-
1.
Drugs which antagonize the indirect effects of angiotensin,
-
2.
Drugs which antagonize the direct effects of angiotensin.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Barer, G. R.: The action of vasopressin, a vasopressin analog (PLV2), oxytocin, angiotensin, bradykinin and theophylline ethylene diamine on renal blood flow in the anesthetized cat. J. Physiol. 169, 67 (1963).
Bianchi, A., De Schaepdryver, A. F., De Vleeschhotjver, G. R., Preziosi, P.: On the pharmacology of synthetic hypertensine. Arch. int. Pharmacodyn. 124, 21 (1960).
Bickerton, R. K., Buckley, J. P.: Evidence for a central mechanism in angiotensin-induced hypertensin. Proc. Soc. exp. Biol. (N. Y.) 106, 834 (1961).
Bisset, G. W., Lewis, G. P.: A spectrum of pharmacological activity in some biologically active peptides. Brit. J. Pharmacol. 19, 168 (1962).
Bock, K. D., Gross, F.: Venous pressor changes after administration of renin, angiotensin and noradrenaline. Naunyn-Schmiedebergs Arch. Pharmakol. exp. Path. 242, 188 (1961).
Braun-Menedez, E., Fascioli, J. C., Leloir, L. F., Munoz, J. M., Taquini, A. C.: Renal hypertension, p. 157. Springfield/Illinois: Charles C. Thomas 1946.
Ctjmmings, J. R., Welter, A. N., Grace, J. L., Jr., Gray, W. D.: Angiotensin blocking actions of guaneydine. J. Pharmacol, exp. Therap. 170, 334 (1969).
Distler, A., Liebau, H., Wolff, H. P.: Action of angiotensin on sympathetic nerve endings in isolated blood vessels. Nature (Lond.) 207, 764 (1965).
Ellis, D. E., Reit, E.: Inhibition of lidoflazine of the contractile response of the rat isolated colon to angiotensin. Brit. Pharmacol. 35, 132 (1969).
Feldberg, W., Lewis, G. P.: The action of peptides on the adrenal medulla. Release of adrenaline by bradykinin and angiotensin. J. Physiol. 171, 98 (1964).
Feldberg, W., Lewis, G. P.: Further studies on the effects of peptides on the suprarenal medulla of the cats. J. Physiol. 178, 239 (1965).
Gagnon, D., Park, W. K., Regoli, D.: Specific antagonists for the myotropic action of angiotensin II and angiotensin I on the isolated rat colon. Brit. J. Pharmacol. 43, 409 (1971).
Gascon, A. L., Walaszek, E. J.: Inhibition of valyl5-angiotensinamide II by osajin. J. Pharm. Pharmacol. 18, 497 (1966).
Godfraind, T.: Pharmacology of angiotensin antagonists: Pharmacology of hormonal polypeptides and proteins. New York: Plenum Press 1968.
Godfraind, T., Kaba, A., Polster, P.: Specific antagonism to the direct and indirect action of angiotensin on isolated guinea-pig ileum. Brit. J. Pharmacol. 28, 93 (1966).
Haefely, W. A., Hurlimakct, A., Thoenen, H.: The effect of bradykinin and angiotensin on ganglionic transmission. Biochem. Pharmacol. 14, 1393 (1965).
Johnson, G., Henning, M., Ablad, B.: Studies on the mechanism of the vasoconstrictor effects of angiotensin II in man. Life Sci. 4, 1549 (1965).
Kaneko, Y., McCubbin, J. W., Page, I. H.: Ability of vasoconstrictor drugs to cause adrenal medullary discharge after “sensitization” by ganglion stimulating agents. Circulât. Res. 9, 1247 (1961).
Katz, Y. J., Moobe, R. S., Velasquez, A. M., Tamosaitis, I. T.: Angiotensin pressor inhibition by aldosterone in the rabbit. Science 141, 725 (1963).
Khairallah, P. A., Page, I. H.: Mechanisms of action of angiotensin and bradykinin on smooth muscle in situ. Amer. J. Physiol. 200, 51 (1961).
Khair allah, P. A., Page, I. H.: Effect of adrenergic agents on responses of smooth muscle to angiotensin. Amer. J. Physiol. 202, 841 (1962).
Khairallah, P. A., Toth, A., Bumpus, F. M.: Analogs of angiotensin II. Mechanism of receptor interaction. J. med. Chem. 13, 181 (1970).
Rhosla, M. C., Kumar, S., Smeby, R. R., Bumpus, F. M.: (1) Solid phase synthesis of [6-argi- nine]-, [4-histidine, 6-tyrosine]- and [8-isoleucine]-angiotensin II. J. med. Chem. 15, 627 (1972).
Khosla, M. C., Leese, R. A., Maloy, W. L., Ferreira, A. T., Smeby, R. R., Bumpus, F. M.: (2) Synthesis of some analogs of angiotensin II as specific antagonists of the parent hormone. J. med. Chem. 15, 792 (1972).
Krasney, J. A., Paudler, F. J., Smith, D. C., Davis, L. D., Youmans, W. B.: Mechanisms of cardioaccelerator action of angiotensin. Amer. J. Physiol. 209, 539 (1965).
Lewis, G. P., Reit, E.: The action of angiotensin and bradykinin on the superior cervival ganglion of the cat. J. Physiol. 179, 538 (1965).
Lewis, G. P., Reit, E.: Further studies on the actions of peptides on the superior cervival ganglion and suprarenal medulla. Brit. J. Pharmacol. 26, 444 (1966).
Marshall, G. R., Vine, W., Needleman, P.: A specific competitive inhibitor of angiotensin II. Proc. nat. Acad. Sci. (Wash.) 67, 1624 (1970).
McGiff, J. C., Fasy, T. M.: The relationship of the renalvascular activity of angiotensin II to the autonomic nervous system. J. clin. Invest. 44, 1911 (1965).
Meier, R., Gross, F., Tripod, J., Turrian, H.: Pharmakologische Charakterisierung von synthetischer Hypertension. Experientia (Basel) 13, 361 (1957).
Meier, R., Tripod, J., Studer, A.: Comparison des propriétés vasculaires peripheriques de Thypertensive synthetique et de divers vasoconstricteurs. Arch. int. Pharmacodyn. 117, 185 (1958).
Page, I. H., McCubbin, J. W.: Renal vascular and systemic arterial pressure responses to nervous and chemical stimulation of the kidney. Amer. J. Physiol. 173, 411 (1953).
Pals, D. T., Masucci, F. D., Denning, G. S., Jr., Srpos, F., Fessleb, D. C.: Role of the pressor action of angiotensin II in experimental hypertension. Circulât. Res. 29, 673 (1971).
Pals, D. T., Masucci, F. D., Sipos, F., Denning, G. S., Jr.: (1) specific competitive antagonist of the vascular action of angiotensin II. Circulât. Res. 29, 664 (1971).
Panisset, J. C., Biron, P., Beaulnes, A.: Effect of angiotensin on the superior cervical ganglion of the cat. Experientia (Basel) 22, 394 (1966).
Peach, M. J., Bumpus, F. M., Khairallah, P. A.: Release of catecholamines by angiotensin I. J. Pharmacol, exp. Ther. 176, 366 (1970).
Regoli, D., Park, W. K.: The pressor and myotropic effects and the antagonistic properties of several analogues of angiotensin II. Canad. J. Physiol. Pharmacol. 50, 99 (1972).
Regoli, D., Park, W. K., Rioux, F., Chan, C. S.: Antagonists of angiotensin, substitution of an aliphatic chain to phenyl ring in position 8. Rev. canad. Biol. 30, 319 (1971).
Regoli, D., Vane, J. R.: A sensitive method for the assay of angiotensin. Brit. J. Pharmacol. 23, 351 (1964).
Renson, J., Barae, G., Bacq, Z. U.: Effect of two synthetic angiotensins on the arterial pressure and nictitating membrane of the cat. C. R. Soc. Biol. (Paris) 153, 1621 (1959).
Robertson, A. L., Khairallah, P. A.: Effects of angiotensin II and some analogs on vascular permeability in the rabbit. Circulât. Res. XXXI, 923 (1972).
Robertson, P. A., Rubin, D.: Stimulation of intestinal nervous elements by angiotensin. Brit. J. Pharmacol. 19, 5 (1962).
Schaper, W. K. A., Jageneau, A. H. M., Xhonneux, R., Van Nueten, J., Jansseu, P. A. J.: Cinnarizine (R516) a specific angiotensin-blocking coronary vasodilator. Life Sci. 2, 963 (1963).
Schild, H. O.: pA. A new scale of the measurement of drug antagonism. Brit. J. Pharmacol. 2, 189 (1947).
Schild, H. G.: Drug antagonism and pAx. Pharmacol. Rev. 9, 242 (1957).
Schumann, H. J., Guther, W.: Untersuchungen zum Wirkungsmechanismus von Angiotensin am solierten Aortenpraparat und am Blutdruck von Ratten und Meerschweinchen. Nauinyn-Schmiedebergs Arch. Pharmak. exp. Path. 256, 169 (1968).
Scroop, G. C., Whelan, R. F.: A central vasomotor action of angiotensin in man. Clin. Sci. 30, 79 (1966).
SujAtt, J. G., Jones, R. E., Bashour, F. A., Kaplan, N. M.: The effect of acute administration of chlorothiazide upon the pressor responsiveness to angiotensin and norepinephrine. Amer. Heart J. 69, 301 (1965).
Trendelenburg, U.: Observation on the ganglion stimulating action of angiotensin and bradykinin. J. Pharmacol, exp. Therap. 154, 418 (1966).
Tûrker, R. K.: Action of angiotensin on the cardiac arrhytmias induced by G-Strophanthine. Experientia (Basel) 20, 707 (1965).
Tûrker, R. K.: Possible postganglionic effect of angiotensin in the isolated perfused cat intestinal segment. Ajch. int. Physiol. 77, 587 (1969).
Tûrker, R. K., Hall, M. M., Yamamoto, M., Sweet, C. S., Bumpus, F. M.: A new long- lasting competitive inhibitor of angiotensin. Science 177, 1203 (1972).
Turker, R. K., Kayaalp, S. O.: (1) Inhibitory effect of angiotensin on intestinal motility of the cat and its relation to sympathetic nervous system. Arch. int. Physiol. Biochim. 75, 735 (1967).
Tûrker, R. K., Kayaalp, S. O.: (2) Effects of lidoflazine on norepinephrine, angiotensin and serotonin responses in isolated smooth muscle preparations. Experientia (Basel) 23, 647 (1967).
Turker, R. K., Kayaalp, S. O., Ôzer, A.: (1) Further studies on lidoflazine (RA7904). Arzneimittel-Forsch. 18, 1209 (1968).
Turker, R. K., Kaymakcalan, S., Ayhan, I. H.: (2) Effect of prostaglandin E1 (PGEX) on the vascular responsiveness to norepinephrine and angiotensin in the anesthetized rat. Arzneimittel-Forsch. 18, 1310 (1968).
Tûrker, R. K., Khairallah, P. A., Kayaalp, S. O., Kaymakcalan, S.: Responses of the nictitating membrane to prostaglandin Ex and angiotensin. Europ. J. Pharmacol. 5, 173 (1969).
Tûrker, R. K., Yamamoto, M., Bumpus, F. M.: (1) A new short-acting antagonist of angiotensin II. Arch. int. Pharmacodyn. 201, 162 (1963).
Tûrker, R. K., Yamamoto, M., Khairallah, P. A., Bumpus, F. M.: Competitive antagonism of 8-Ala-angiotensin II to angiotensin I and II on the isolated rabbit aorta and rat ascending colon. Europ. J. Pharmacol. 15, 285 (1971).
Van Nueten, J., Dresse, A., Dony, J.: Action antagoniste de la cinnarizine vis-à-vis de Fangiotensin in vitro. C. R. Soc. Biol. (Paris) 158, 1750 (1964).
Worcel, M., Papadimitriou, A., Meyer, P.: Blockade of the effects of angiotensin, oxytocin, norepinephrine, 5-hydroxytryptamine and acetylcholine by guancydine. J. Pharmacol, exp. Ther. 179, 42 (1971).
Yamamoto, M., Tûrker, R. K., Khairallah, P. A., Bumpus, F. M.: A potent competitive antagonist of angiotensin II. Europ. J. Pharmacol. 18, 316 (1972).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Türker, R.K., Page, I.H., Bumpus, F.M. (1974). Antagonists of Angiotensin II. In: Page, I.H., Bumpus, F.M. (eds) Angiotensin. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 37. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65600-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-65600-2_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65602-6
Online ISBN: 978-3-642-65600-2
eBook Packages: Springer Book Archive